The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 15, 2025

Filed:

Aug. 30, 2023
Applicant:

Aerin Medical Inc., Sunnyvale, CA (US);

Inventors:

Scott J. Wolf, Menlo Park, CA (US);

Andrew Frazier, Sunnyvale, CA (US);

Assignee:

Aerin Medical Inc., Mountain View, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61B 18/14 (2006.01); A61B 18/02 (2006.01); A61B 18/08 (2006.01); A61B 18/16 (2006.01); A61B 18/18 (2006.01); A61B 18/20 (2006.01); A61F 5/08 (2006.01); A61M 25/00 (2006.01); A61M 25/10 (2013.01); A61N 7/02 (2006.01); A61B 18/00 (2006.01);
U.S. Cl.
CPC ...
A61B 18/1485 (2013.01); A61B 18/02 (2013.01); A61B 18/082 (2013.01); A61B 18/1442 (2013.01); A61B 18/16 (2013.01); A61B 18/1815 (2013.01); A61B 18/20 (2013.01); A61F 5/08 (2013.01); A61M 25/0084 (2013.01); A61M 25/10 (2013.01); A61N 7/022 (2013.01); A61B 2018/00005 (2013.01); A61B 2018/00023 (2013.01); A61B 2018/0022 (2013.01); A61B 2018/00327 (2013.01); A61B 2018/00577 (2013.01); A61B 2018/00595 (2013.01); A61B 2018/00702 (2013.01); A61B 2018/00821 (2013.01); A61B 2018/00922 (2013.01); A61B 2018/00994 (2013.01); A61B 2018/0225 (2013.01); A61B 2018/0293 (2013.01); A61B 2018/1425 (2013.01); A61B 2018/143 (2013.01); A61B 2018/1869 (2013.01); A61M 2025/0091 (2013.01); A61M 2025/105 (2013.01);
Abstract

Systems and methods for treating a patient's mucus hypersecretion condition are disclosed herein. Certain implementations may involve a method for reducing mucus secretion in an upper airway of a patient to treat at least one of post nasal drip or chronic cough. The method may include advancing a treatment delivery portion of an energy-based treatment device into a nostril of the patient. The treatment delivery portion may contact mucosal tissue of the upper airway without piercing the mucosal tissue. The treatment delivery portion may deliver treatment to at least one tissue selected from the group of the mucosal tissue and another tissue underlying the mucosal tissue to modify a property of the at least one tissue and thus treat at least one of post nasal drip or chronic cough in the patient.


Find Patent Forward Citations

Loading…